Fund Holdings — Foresite Capital Management V, LLC

Total Portfolio Value:
$80.73M
Total Bought:
$8.66M
Total Sold:
$4.38M
Net Transaction:
+$4.29M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CG Oncology, Inc.(CGON)859,0501,004,050+145,000$21.04M$26.11M32.34%+$5.07M
Alumis Inc5,779,3485,779,3480$35.49M$17.34M21.48%-$18.15M
Disc Medicine, Inc.(IRON)299,069299,0690$14.85M$15.84M19.62%+$992.9K
Hims & Hers Health, Inc.CL A(HIMS)273,151273,1510$8.07M$13.62M16.87%+$5.54M
Maze Therapeutics, Inc.(MAZE)345,191345,1910$3.80M$4.24M5.25%+$434.9K
Lyell Immunopharma, Inc.(LYEL)0406,652+406,652$0$3.59M4.45%+$3.59M
Lyell Immunopharma, Inc.(LYEL)8,133,0470-8,133,047$4.38M$0—-$4.38M
Page 1 of 1
Foresite Capital Management V, LLC — 13F Holdings — Q2 2025 | TickerTrail